Published in Neurology on November 23, 2011
Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression. Neuromuscul Disord (2014) 1.19
The role of fibrosis in Duchenne muscular dystrophy. Acta Myol (2012) 1.04
Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone. Acta Myol (2012) 0.92
Permanent muscular sodium overload and persistent muscle edema in Duchenne muscular dystrophy: a possible contributor of progressive muscle degeneration. J Neurol (2012) 0.90
Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? EPMA J (2013) 0.89
23Na Magnetic Resonance Imaging of the Lower Leg of Acute Heart Failure Patients during Diuretic Treatment. PLoS One (2015) 0.88
Na+ dysregulation coupled with Ca2+ entry through NCX1 promotes muscular dystrophy in mice. Mol Cell Biol (2014) 0.86
Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy. Cell Death Differ (2015) 0.81
Quantitative techniques for musculoskeletal MRI at 7 Tesla. Quant Imaging Med Surg (2016) 0.76
Quantitative assessment of muscle injury by (23)Na magnetic resonance imaging. Springerplus (2016) 0.75
Increased collagen cross-linking is a signature of dystrophin-deficient muscle. Muscle Nerve (2016) 0.75
Quantitative sodium magnetic resonance imaging of cartilage, muscle, and tendon. Quant Imaging Med Surg (2016) 0.75
The skeletal muscle chloride channel in dominant and recessive human myotonia. Science (1992) 4.28
Voltage-gated ion channels and hereditary disease. Physiol Rev (1999) 2.76
Membrane changes in cells from myotonia patients. Physiol Rev (1985) 2.38
A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet (1994) 2.22
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve (1987) 1.94
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology (2007) 1.90
Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol (1993) 1.88
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. Neurology (2010) 1.84
Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain (2001) 1.82
Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release. J Physiol (2000) 1.76
Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet (1994) 1.67
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58
Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand (2009) 1.57
Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature (1990) 1.57
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand (1997) 1.57
Myotonia fluctuans. Arch Neurol (1990) 1.56
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve (2000) 1.50
Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve (1984) 1.44
Two cases of adynamia episodica hereditaria: in vitro investigation of muscle cell membrane and contraction parameters. Muscle Nerve (1983) 1.39
Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J Physiol (1995) 1.36
Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol (1994) 1.33
Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet (1994) 1.32
Ion channels and epilepsy. Am J Med Genet (2001) 1.32
Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology (1994) 1.31
4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim Biophys Acta (1996) 1.29
Regulation of the purified Ca2+ release channel/ryanodine receptor complex of skeletal muscle sarcoplasmic reticulum by luminal calcium. Pflugers Arch (1996) 1.29
Paramyotonia congenita: the R1448P Na+ channel mutation in adult human skeletal muscle. Ann Neurol (1996) 1.28
A novel SCN4A mutation causing myotonia aggravated by cold and potassium. Hum Mol Genet (1993) 1.26
Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet (2001) 1.25
Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. J Clin Invest (1999) 1.25
Role in fast inactivation of the IV/S4-S5 loop of the human muscle Na+ channel probed by cysteine mutagenesis. J Physiol (1997) 1.22
Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur J Neurosci (2001) 1.19
Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology (2004) 1.17
A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol (1999) 1.17
Active fascial contractility: Fascia may be able to contract in a smooth muscle-like manner and thereby influence musculoskeletal dynamics. Med Hypotheses (2005) 1.16
Overexcited or inactive: ion channels in muscle disease. Cell (1995) 1.15
Drug-induced myotonia in human intercostal muscle. Muscle Nerve (1988) 1.13
The resting membrane parameters of human intercostal muscle at low, normal, and high extracellular potassium. Muscle Nerve (1984) 1.10
Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet (1995) 1.10
Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness. Neurology (2006) 1.10
Altered sodium channel behaviour causes myotonia in dominantly inherited myotonia congenita. Neuromuscul Disord (1991) 1.08
Calcium currents and transients of native and heterologously expressed mutant skeletal muscle DHP receptor alpha1 subunits (R528H) FEBS Lett (1998) 1.07
Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol (1995) 1.06
Adynamia episodica hereditaria: what causes the weakness? Muscle Nerve (1989) 1.05
Membrane defects in paramyotonia congenita with and without myotonia in a warm environment. Muscle Nerve (1981) 1.05
A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro. J Physiol (2000) 1.05
Voltage-activated calcium signals in myotubes loaded with high concentrations of EGTA. Biophys J (2003) 1.05
Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem (1997) 1.02
Paramyotonia, potassium-aggravated myotonias and periodic paralyses. 37th ENMC International Workshop, Naarden, The Netherlands, 8-10 December 1995. Neuromuscul Disord (1997) 1.02
Role in fast inactivation of conserved amino acids in the IV/S4-S5 loop of the human muscle Na+ channel. Neurosci Lett (1996) 1.01
On identification of Na(+) channel gating schemes using moving-average filtered hidden Markov models. Eur Biophys J (1999) 1.01
Characteristics of Na+ channels and Cl- conductance in resealed muscle fibre segments from patients with myotonic dystrophy. J Physiol (1990) 1.00
Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation. Neurology (2005) 1.00
External tetraethylammonium as a molecular caliper for sensing the shape of the outer vestibule of potassium channels. Biophys J (1999) 0.99
Proof of a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection of a 4 base pair deletion. Hum Mol Genet (1994) 0.98
Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.98
Familial cramp due to potassium-aggravated myotonia. J Neurol Neurosurg Psychiatry (1998) 0.98
Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflugers Arch (1988) 0.97
Effects of temperature and mexiletine on the F1473S Na+ channel mutation causing paramyotonia congenita. Pflugers Arch (1998) 0.96
Expression and functional characterization of the cardiac L-type calcium channel carrying a skeletal muscle DHP-receptor mutation causing hypokalaemic periodic paralysis. Pflugers Arch (1996) 0.96
A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology (1997) 0.96
Activation of the skeletal muscle ryanodine receptor by suramin and suramin analogs. Mol Pharmacol (1996) 0.96
SCN4A-associated hypokalemic periodic paralysis merits a trial of acetazolamide. Neurology (2004) 0.95
Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19. Genomics (1991) 0.94
Electrical myotonia in heterozygous carriers of recessive myotonia congenita. Muscle Nerve (1999) 0.94
Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet (1996) 0.93
Transient weakness and altered membrane characteristic in recessive generalized myotonia (Becker). Muscle Nerve (1988) 0.93
Linkage data suggesting allelic heterogeneity for paramyotonia congenita and hyperkalemic periodic paralysis on chromosome 17. Hum Genet (1991) 0.93
Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes. J Physiol (1995) 0.92
The use of Fura-2 to estimate myoplasmic [Ca2+] in human skeletal muscle. Cell Calcium (1989) 0.92
Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? Eur J Hum Genet (2003) 0.92
EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. Second of two parts. Eur J Neurol (2001) 0.91
Neuromuscular transmission in the mdx mouse. Muscle Nerve (1990) 0.90
A novel N440K sodium channel mutation causes myotonia with exercise-induced weakness--exclusion of CLCN1 exon deletion/duplication by MLPA. Acta Myol (2011) 0.90
Permanent muscular sodium overload and persistent muscle edema in Duchenne muscular dystrophy: a possible contributor of progressive muscle degeneration. J Neurol (2012) 0.90
Confirmation of linkage of hyperkalaemic periodic paralysis to chromosome 17. J Med Genet (1991) 0.89
In vivo sodium channel structure/function studies: consecutive Arg1448 changes to Cys, His, and Pro at the extracellular surface of IVS4. Soc Gen Physiol Ser (1995) 0.89
4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle. Biochem Pharmacol (1996) 0.89
A possible role of the junctional face protein JP-45 in modulating Ca2+ release in skeletal muscle. J Physiol (2006) 0.88
Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene. Am J Hum Genet (1995) 0.88
Mutant channels contribute <50% to Na+ current in paramyotonia congenita muscle. Brain (1999) 0.88
Human muscle voltage-gated ion channels and hereditary disease. Curr Opin Pharmacol (2001) 0.88